Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. PARP inhibitors and bevacizumab for treating advanced ovarian cancer
Drug guidance

PARP inhibitors and bevacizumab for treating advanced ovarian cancer

Cancer

Gynaecological

2 January 2024

Guidance Recommendations

Funding status

Back to top